Loading
Latest filing published 26 Feb 2024 for Ovid Therapeutics Inc..
No signal scores available.
Only one filing by Thomas Michael Perone is known so far (26 February 2024): a share grant, in Ovid Therapeutics Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration